Hi everyone. I'm Maggie McGrath, editor of Forbes Women.

According to the American Cancer Society, one in eight women in the United States

will develop breast cancer.

One in 36 will die from the disease. Other research

shows that up to 10% of breast and ovarian cancer cases are caused by genetics and yet new research shows that genetic screening is not

reaching the patients who need it the most.

Jo Jimsky.

He's the director of Genomics at Renown Health and he was deeply involved in this research.

Joe, thanks so much for being here.

Start at the beginning.

What made you want to do this research?

Was it a patient experience you had?

Was it a story that you heard?

Or was it prior research that led to this article now coming out in Jama?

Sure, so like many people I had to deal with cancer in my family and was actually a researcher in

in biophysics and after my father passed away when I was age 27 I felt like

My research should have more of a human health focus and was fortunate enough to start this

project in Northern Nevada called the Healthy Nevada Project whose aim is to assess the impact of genetic screening on individuals in our

population and that's what led to a series of studies on links to breast cancer.

So this new study that came out, there was a figure in it, I was reading just the parts that I could

understand to someone without a medical license, but there's evidence that suggests that

up to 80% of patients with a pathogenic or likely pathogenic percent of

...